Events

Tuesday, October 27
6:00 - 7:30 pm GMT+3
11:00 am - 12:30 pm EDT 

Since the World Health Organization officially declared COVID-19 a global pandemic in March 2020, the worldwide priority of finding effective, scalable treatments that are safe and tested has been escalating. Researchers across the globe are working relentlessly to find a vaccine against SARS-CoV-2. Despite vaccination development typically taking years from conception to market availability, experts are attempting to fast-track the process for a successful COVID-19 vaccine candidate and multiple public-private partnerships are underway. There are currently several pathways in experimental clinical trials to prove the efficacy of vaccines, therapeutics, and diagnostics.

This webinar brings together leading experts in virology and immunology to offer their perspectives on the global progress towards developing a vaccine. Panelists will discuss the vaccine’s development cycle, experimental clinical trials underway, as well as issues of global access to treatment and vaccines.

Speakers

Seth Berkley, Chief Executive Officer, GAVI Alliance

Susan Bueno, Associate Professor, Department of Molecular Genetics and Microbiology, Universidad Católica de Chile

Mussaad M. Al-Razouki, Chief Business Development Officer, Kuwait Life Sciences Company and Board Member, The Arab Company for Drug Industry and Medical Appliances

Rana Hajjeh, Director of Program Management, WHO Regional Office for the Eastern Mediterranean

Moderated by Wafaa El-Sadr, University Professor of Epidemiology and Medicine, Director of ICAP, and Director of the Global Health Initiative, Mailman School of Public Health, Columbia University

Introduction by Safwan Masri, Executive Vice President for Global Centers and Global Development, Columbia University

In partnership with